Back
Return
Biography
Dr. Deborah Jean Verran

Dr. Deborah Jean Verran

Royal Prince Alfred Hospital, Australia


Email: verran@ausdoctors.net


Qualification

1981 MBChB, University of Otago Medical School, New Zealand


Publications

  1. Immunosuppressive Effects of Tripterygium Wilfordii Hook(TWHF) In A Rat Liver Transplant Model. Trans Proc. B Ren, J Sun, C Hu, L Cong, L Zhang, N King, D Verran, AGR Sheil. Trans Proc 2001; 33: 520-521.
  2. Inferior Liver Allograft Survival from Cadaveric Donors > 50 Years of Age? D Verran, A Gurkan, P Dilworth, D Painter, A Chui, S Dorney, A Shun, D Koorey, G McCaughan, AGR Sheil. Clin Transpl 2001; 15: 106-110.
  3. A Giant Multiacinar Macroregenerative Nodule In An Explanted Liver. A Gurkan, MF Sherlock, AK Chui, R Thomson, D Verran, AGR Sheil, D Painter. Transplantation 2001; 72: 538-9.
  4. Hepatic Artery Thrombosis(HAT) and Intra-Operative Hepatic Artery Flow Rates in Adult Orthotopic Liver Transplantation(OLT). M Lin, M Crawford, J Fisher, K Hitos, D Verran. Aus & NZ J Surg 2002; 72: 798.
  5. Incisional Hernia Following Orthotopic Liver Transplantation. LW Shi, D Verran, ARN Rao, GJ Stewart, GW McCaughan. Trans Proc 2003, 35; 425-426.
  6. Primary Liver Transplantation With Pre-existing Portal Vein Thrombosis. LW Shi, D Verran, D Chang, C Drenckahn, G Stewart, G McCaughan. Trans Proc 2003; 35: 354-355.
  7. Cytomegalovirus Serology Status and Early Hepatic Artery Thrombosis Following Adult Liver Transplantation. LW Shi, GJ Stewart, D Verran, M Maley, G McCaughan. Trans Proc 2003; 35: 421-422.
  8. Clinical Experience Gained From The Use of 120 Steatotic Donor Livers For Orthotopic Liver Transplantation. D Verran, T Kusyk, D Painter et al. Liver Transplantation 2003; 9: 500-505.
  9. Liver Retransplantation in an infant requiring cavoportal hemi transposition. Verran D, Crawford M, Stormon M, Shun A. Pediatr Transplantation 2004; 8: 416-419.
  10. Liver Transplantation Utilizing Paediatric Cadaver Donor Livers. Tanaka H, Verran D, Shun A, Dorney S, Stormon M, Fisher J, McCaughan G. Pediatr Transpl 2005; 9(1) 47-51.
  11. Increased Risk of Haemorrhagic Complications in Renal Allograft Recipients Receiving Systemic Heparin Early Post Transplantation. T Kusyk, D Verran, G Stewart, B Ryan, J Fisher, K Tsacalos, S Chadban, J Eris. Trans Proc 2005; 37: 1026-1028.
  12. Biopsy of Potential Cadaveric Renal Allografts at the Time of Retrieval. Deborah Verran, Adrian Sheridan, Alison Barnwell, Marnie Berriman, Jeremy Chapman. Nephr 2005; 10(4) 414-7.
  13. Deceased Kidney Donor Suitability Guidelines. Verran D, Robertson A, Chapman J, Chadban S. Nephrology 2005; 10: S116-S132.
  14. Living Donor Liver Transplantation-Adult Donor Outcomes: A Systematic Review. Middleton PF, Duffield M, Lynch SV, Padbury RT, House T, Stanton P, Verran D, Maddern G. Liver Transplantation 2006; 12:24-30.
  15. Arterial Vascular Conduits in Adult Orthotopic Liver Transplant recipients. Liu T, Dilworth P, Sosef M, Wang C, Crawford M, Gallagher J, Verran D. ANZ J Surg 2006; 76: 64-67.
  16. Long Term Lamivudine Monotherapy Prevents Development of Hepatitis B Virus Infection In Hepatitis B Surface-Antigen Negative Liver Transplant Recipients From Hepatitis B Core-antibody-positive Donors. Prakaso E, Strasser S, Koorey D, Verran D, McCaughan GW. Clin Transplant 2006; 20: 369-373.
  17. Hereditary Lysozyme Amyloidosis: Spontaneous Hepatic Rupture(15 years apart) in Mother and Daughter. Role of Emergency Liver Transplantation. Loss M, Ng WS, Karim RZ et al. Liver Transpl 2006; 12: 1152-1155.
  18. Outcomes of Patients With Hepatocellular Carcinoma Referred to a Tertiary Centre With Availability of Multiple Treatment Options. Perry JF, Charlton B, Koorey DJ, Waugh R, Gallagher J, Crawford AM, Verran DJ, McCaughan GW, Strasser S. Liver International 2007, 27(9): 1240-8.
  19. Chimerism and Tolerance in a Recipient of a Deceased Donor Liver Transplant. SI Alexander, N Smith, M Hu, D Verran et al. N Eng J Med 2008; 358: 369-374.
  20. Usage and Outcomes of Deceased Donor Liver Allografts with Preprocurement Injury from Blunt Trauma. Geenen I et al. Liver Transpl 2009;15: 321-325.
  21. Poorer survival in patients whose explanted hepatocellular carcinoma(HCC) exceeds Milan or UCSF Criteria. An analysis of liver transplantation in HCC in Australia and New Zealand. Chen JW, Kow L, Verran DJ et al. HPB 2009; 11: 81-89.
  22. Early High Peak Hepatitis C Viral Load Levels Independently Predict Hepatitis C-Related Liver Failure Post-Liver Transplantation. Shackel NS, Jamias J, Rahman W, Prakaso E, Strasser SI, Koorey DJ, Crawford MD, Verran DJ, Gallagher J, McCaughan GW. Liver Transplantation 2009; 15: 709-718.
  23. Donor and recipient selection leads to good patient and graft outcomes for right lobe split versus whole graft liver transplantation in adults. Sandroussi C, Crawford M, Lockwood D, Tang P, Gallagher J, Pleass H, Strasser S, Shackel N, McCaughan G, Verran D. Liver Transplantation 2009; 15: 1586-1593.
  24. Biliary Strictures and Hepatic Artery Flow Abnormalities in Split Liver Transplants. O’Loughlin EV, Stormon MO, Shun A, Verran D, Jermyn V, Wong C, Lord D. Ped Transpl 2010; 14: 121-125.
  25. Liver Transplantation in Children With Hyper-Reduced Grafts-A Single Centre Experience. Thomas N, Thomas G, Verran D, Stormon M, O’Loughlin E, Shun A. Ped Transpl 2010; 14(1) 121-5.
  26. Increasing Liver Transplantation Waiting List Mortality: A Report from the Australian National Liver Transplantation Unit Sydney. Prakaso E, Verran D, Dilworth P et al. Int Med Journal 2010; 40: 619-625.
  27. Prosthetic Lower Extremity Hemodialysis Access Grafts Have Satisfactory Patency Despite High Incidence of Infection. I Geenen et al. J Vasc Surg 2010; 52: 1546-50.